Arrowhead Research reported $41.55M in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Agios Pharmaceuticals AGIO:US $ -104827000 13.68M
Arrowhead Research ARWR:US $ 41.55M 104.87M
Cerulean Pharma CERU:US $ -9543120 3.13M
IONIS PHARMACEUT IONS:US $ 221M 306.85M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Nektar Therapeutics NKTR:US $ -112910000 686K
Novartis NOVN:VX 2.88B 596M
Tg Therapeutics TGTX:US $ -92947000 7.82M
Xencor XNCR:US $ 26.47M 65.19M